Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study.

Ola Kally Magnusdottir, Rikard Landberg, Ingibjorg Gunnarsdottir, Lieselotte Cloetens, Björn Åkesson, Fredrik Rosqvist, Ursula Schwab, Karl-Heinz Herzig, Janne Hukkanen, Markku J Savolainen, Lea Brader, Kjeld Hermansen, Marjukka Kolehmainen, Kaisa Poutanen, Matti Uusitupa, Ulf Risérus, Inga Thorsdottir

Research output: Contribution to journalArticlepeer-review

30 Citations (SciVal)

Abstract

Few studies have explored the possible plasma cholesterol lowering effects of rye consumption. The aim of this secondary analysis in the SYSDIET study was to investigate the association between plasma alkylresorcinols (AR), a biomarker for whole grain wheat and rye intake, and blood lipid concentrations in a population with metabolic syndrome. Furthermore, we analyzed the associations between the AR C17∶0/C21∶0 ratio, a suggested marker of the relative intake of whole grain/bran rye, and blood lipid concentrations.
Original languageEnglish
Article numbere110827
JournalPLoS ONE
Volume9
Issue number10
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Biochemistry and Molecular Biology

Fingerprint

Dive into the research topics of 'Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study.'. Together they form a unique fingerprint.

Cite this